Literature DB >> 19754446

The dynamic Rab11-FIPs.

Conor P Horgan1, Mary W McCaffrey.   

Abstract

The Rab11-FIPs (Rab11-family interacting proteins; also known as FIPs) constitute an evolutionarily conserved protein family that act as effector molecules for multiple Rab and Arf (ADP-ribosylation factor) GTPases. They were initially characterized by their ability to bind Rab11 subfamily members via a highly-conserved C-terminal RBD (Rab11-binding domain). Resolution of the crystal structure of Rab11 in complex with FIPs revealed that the RBD mediates homodimerization of the FIP molecules, creating two symmetrical interfaces for Rab11 binding and leading to the formation of a heterotetrameric complex between two FIP and two Rab11 molecules. The FIP proteins are encoded by five genes and alternative splicing has been reported. Based on primary structure, the FIPs were subcategorized into two classes: class I [Rip11, FIP2 and RCP (Rab-coupling protein)] and class II (FIP3 and FIP4). Recent studies have identified the FIPs as key players in the regulation of multiple distinct membrane trafficking events. In this mini-review, we summarize the Rab11-FIP field and discuss, at molecular and cellular levels, the recent findings on FIP function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754446     DOI: 10.1042/BST0371032

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  81 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

Review 2.  The role of endosomal-recycling in long-term potentiation.

Authors:  Eoin E Kelly; Conor P Horgan; Mary W McCaffrey; Paul Young
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

3.  Kinetics of G-protein-coupled receptor endosomal trafficking pathways revealed by single quantum dots.

Authors:  Katye M Fichter; Marc Flajolet; Paul Greengard; Tania Q Vu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-12       Impact factor: 11.205

4.  Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15.

Authors:  Susan Chi; Hong Cao; Yu Wang; Mark A McNiven
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

5.  The Rab11 pathway is required for influenza A virus budding and filament formation.

Authors:  Emily A Bruce; Paul Digard; Amanda D Stuart
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

6.  Inducible protein traps with dominant phenotypes for functional analysis of the Drosophila genome.

Authors:  Swetha Singari; Naureen Javeed; Nicholas J Tardi; Suresh Marada; Jeff C Carlson; Steven Kirk; Judith M Thorn; Kevin A Edwards
Journal:  Genetics       Date:  2013-10-30       Impact factor: 4.562

7.  Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channels.

Authors:  Jabe M Best; Jason D Foell; Courtney R Buss; Brian P Delisle; Ravi C Balijepalli; Craig T January; Timothy J Kamp
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-19       Impact factor: 4.249

8.  Slitrk5 Mediates BDNF-Dependent TrkB Receptor Trafficking and Signaling.

Authors:  Minseok Song; Joanna Giza; Catia C Proenca; Deqiang Jing; Mark Elliott; Iva Dincheva; Sergey V Shmelkov; Jihye Kim; Ryan Schreiner; Shu-Hong Huang; Eero Castrén; Rytis Prekeris; Barbara L Hempstead; Moses V Chao; Jason B Dictenberg; Shahin Rafii; Zhe-Yu Chen; Enrique Rodriguez-Boulan; Francis S Lee
Journal:  Dev Cell       Date:  2015-05-21       Impact factor: 12.270

Review 9.  Dynein activators and adaptors at a glance.

Authors:  Mara A Olenick; Erika L F Holzbaur
Journal:  J Cell Sci       Date:  2019-03-15       Impact factor: 5.285

10.  Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.

Authors:  Lipsa Das; Jaime M C Gard; Rytis Prekeris; Raymond B Nagle; Colm Morrissey; Beatrice S Knudsen; Cindy K Miranti; Anne E Cress
Journal:  Mol Cancer Res       Date:  2018-05-14       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.